Close Menu

NEW YORK­ – NanoString Technologies said today that it intends to offer, subject to market conditions and other factors, $175 million worth of convertible senior notes due 2025 in a private placement to qualified institutional buyers.

The firm also plans to grant initial purchasers of the notes a 13-day option to purchase up to an additional $26.25 million aggregate principal amount of the notes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.